Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XSN Capsule for ventricular premature beats
ChiCTR-TRC-14004180Phase 4Completed
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Dec 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of xinsuning and mexiletine in Premature ventricular complexes (PVC) (3 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: Therapeutic effect in 24-hour dynamic ECG (Holter) of ventricular premature beats. Started Dec 2013; status: completed.
02
Drugs
xinsuningmexiletine
03
Conditions
Premature ventricular complexes (PVC)
Beyond the preview
Go deeper on ChiCTR-TRC-14004180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004180.